BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 30090417)

  • 1. The inhibition of cytochrome P450 2A13-catalyzed NNK metabolism by NAT, NAB and nicotine.
    Liu X; Zhang J; Zhang C; Yang B; Wang L; Zhou J
    Toxicol Res (Camb); 2016 Jul; 5(4):1115-1121. PubMed ID: 30090417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro metabolism of N'-Nitrosonornicotine catalyzed by cytochrome P450 2A13 and its inhibition by nicotine, N'-Nitrosoanatabine and N'-Nitrosoanabasine.
    Liu X; Zhang J; Wang L; Yang B; Zhang C; Liu W; Zhou J
    Chem Biol Interact; 2016 Dec; 260():263-269. PubMed ID: 27567546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative metabolism of the tobacco-specific nitrosamines 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol by rat cytochrome P450 2A3 and human cytochrome P450 2A13.
    Jalas JR; Ding X; Murphy SE
    Drug Metab Dispos; 2003 Oct; 31(10):1199-202. PubMed ID: 12975327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) by human cytochrome P450 1A2 and its inhibition by phenethyl isothiocyanate.
    Smith TJ; Guo Z; Guengerich FP; Yang CS
    Carcinogenesis; 1996 Apr; 17(4):809-13. PubMed ID: 8625495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stereoselective metabolism of nicotine and tobacco-specific N-nitrosamines to 4-hydroxy-4-(3-pyridyl)butanoic acid in rats.
    Trushin N; Hecht SS
    Chem Res Toxicol; 1999 Feb; 12(2):164-71. PubMed ID: 10027794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of CYP2A13 in the bioactivation and lung tumorigenicity of the tobacco-specific lung procarcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone: in vivo studies using a CYP2A13-humanized mouse model.
    Megaraj V; Zhou X; Xie F; Liu Z; Yang W; Ding X
    Carcinogenesis; 2014 Jan; 35(1):131-7. PubMed ID: 23917075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tobacco-Specific Nitrosamines in the Tobacco and Mainstream Smoke of U.S. Commercial Cigarettes.
    Edwards SH; Rossiter LM; Taylor KM; Holman MR; Zhang L; Ding YS; Watson CH
    Chem Res Toxicol; 2017 Feb; 30(2):540-551. PubMed ID: 28001416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for endogenous formation of tobacco-specific nitrosamines in rats treated with tobacco alkaloids and sodium nitrite.
    Carmella SG; Borukhova A; Desai D; Hecht SS
    Carcinogenesis; 1997 Mar; 18(3):587-92. PubMed ID: 9067560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of nicotine and tobacco-specific nitrosamines on the metabolism of N'-nitrosonornicotine and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone by rat oral tissue.
    Murphy SE; Heiblum R
    Carcinogenesis; 1990 Sep; 11(9):1663-6. PubMed ID: 2205411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of Nitrosamide Formation in the Cytochrome P450-Mediated Metabolism of Tobacco-Specific Nitrosamines.
    Carlson ES; Upadhyaya P; Hecht SS
    Chem Res Toxicol; 2016 Dec; 29(12):2194-2205. PubMed ID: 27989137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nicotine Inhibits the Cytotoxicity and Genotoxicity of NNK Mediated by CYP2A13 in BEAS-2B Cells.
    Sun Y; Wang H; Chen H; Zhang S; Li J; Zhang J; Tian J; Zhang Y; Hou H; Hu Q
    Molecules; 2022 Jul; 27(15):. PubMed ID: 35956805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) by cytochrome P450IIB1 in a reconstituted system.
    Guo Z; Smith TJ; Ishizaki H; Yang CS
    Carcinogenesis; 1991 Dec; 12(12):2277-82. PubMed ID: 1747927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nicotine and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone binding and access channel in human cytochrome P450 2A6 and 2A13 enzymes.
    DeVore NM; Scott EE
    J Biol Chem; 2012 Aug; 287(32):26576-85. PubMed ID: 22700965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nicotine and 4-(methylnitrosamino)-1-(3-pyridyl)-butanone metabolism by cytochrome P450 2B6.
    Dicke KE; Skrlin SM; Murphy SE
    Drug Metab Dispos; 2005 Dec; 33(12):1760-4. PubMed ID: 16174803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of nicotine infusion on the metabolism of the tobacco carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in rats.
    Keyler D; Pentel PR; Kuehl G; Collins G; Murphy SE
    Cancer Lett; 2003 Dec; 202(1):1-9. PubMed ID: 14643020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in mouse lung microsomes and its inhibition by isothiocyanates.
    Smith TJ; Guo ZY; Thomas PE; Chung FL; Morse MA; Elkind K; Yang CS
    Cancer Res; 1990 Nov; 50(21):6817-22. PubMed ID: 2208146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic effects of CYP2A6 and CYP2A13 on 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK)-induced gene mutation--a mammalian cell-based mutagenesis approach.
    Chiang HC; Wang CY; Lee HL; Tsou TC
    Toxicol Appl Pharmacol; 2011 Jun; 253(2):145-52. PubMed ID: 21473878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone by inducible and constitutive cytochrome P450 enzymes in rats.
    Guo Z; Smith TJ; Thomas PE; Yang CS
    Arch Biochem Biophys; 1992 Oct; 298(1):279-86. PubMed ID: 1524438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone by dietary benzaldehydes.
    Morse MA; Kresty LA; Toburen AL
    Cancer Lett; 1995 Nov; 97(2):255-61. PubMed ID: 7497471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nicotine Component of Cigarette Smoke Extract (CSE) Decreases the Cytotoxicity of CSE in BEAS-2B Cells Stably Expressing Human Cytochrome P450 2A13.
    Ji M; Zhang Y; Li N; Wang C; Xia R; Zhang Z; Wang SL
    Int J Environ Res Public Health; 2017 Oct; 14(10):. PubMed ID: 29027939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.